-
2024-514991-41-01
4
Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cel
-
2024-510596-37-00
6
low ovarian reserve according to Bologna criteria and carriers of andr
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2023-509392-17-00
5
Relapsed Acute Lymphoblastic Leukemia (ALL)
-
2024-510596-37-01
5
low ovarian reserve according to Bologna criteria and carriers of andr
-
2024-511054-50-00
10
HIV-1 Infection
-
2024-513676-18-00
5
Transthyretin Amyloidosis
-
2024-513724-42-00
10
Medulloblastoma
-
2024-516236-10-00
4
Triple-negative breast cancer
-
2024-516436-10-00
5
Acute myeloid leukemia
-
2024-518199-30-00
9
Soft tissue sarcoma patients
-
2024-518420-80-00
5
Primary infection prophylaxis for secondary immunodeficiency (SID) in
-
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2024-519818-31-01
5
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec
-
2025-520471-29-00
5
Locally advanced adenocarcinoma of the colon and upper rectum with mic
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-520565-51-00
5
small cell lung cancer
-
2025-520887-17-00
6
Post-traumatic brain contusion with edema
-
2025-520954-12-00
6
Atrial Fibrillation
Device thrombosis post-Left Atrial Appendage Closu
-
2025-521086-28-00
6
CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoria
-
2025-521230-29-00
5
Allergic rhinoconjunctivitis to Dermatophagoides pteronyssinus and Der
-
2025-521388-11-00
4
Staphylococcus aureus bacteraemia
-
2025-521587-35-00
5
Metastatic colorectal cancer
-
2025-521989-95-00
9
Advanced/Metastatic Non-squamous Non-Small Cell Lung Cancer